Inside Innovation

Dr. Anthony Fauci, President Biden’s chief medical advisor, stopped in Seattle to speak with Fred Hutchinson Cancer Center and throw the first pitch at the

Three Seattle-area biotech startups are on the rise, according to venture capital firms placing their bets on who will be taking off over the next

Seattle-based biotech company Seagen recently released early findings from a trial of its drug Padcev in combination with Merck‘s Keytruda to treat patients with specific

Bristol Myers Squibb (BMS) ranked fourth in a new report focused on pharma companies’ diversity, equity and inclusion rankings. Bayer, Gilead Sciences and Sanofi were

Seattle-based biotech AltPep Corp. recently raised $44.4 million in equity funding as part of the company’s goal to raise $75 million for Alzheimer’s research. AltPep

Ozette Technologies, a single-cell analysis startup with roots in Seattle, has raised $26 million in a new funding round led by Madrona Partners and Microsoft,

Bothell-based Fujifilm Sonosite Inc., a manufacturer of ultrasound devices, has appointed Richard Fabian as its new CEO. Fabian started with the company as the chief

The University of Washington’s Institute for Protein Design (IPD) is an innovation factory creating a culture of collaboration among software engineers, drug development experts and

Atossa Therapeutics, a Seattle-based biotech company, paid $3 million for exclusive rights to negotiate an acquisition of an unnamed company in the pre-clinical stages of

A COVID-19 vaccine developed by UW Medicine researchers is the first COVID therapeutic technology from the Seattle health care system to be approved for patient

Seattle juggernauts Fred Hutch Cancer Research Center and Amazon are joining forces to develop early-stage cancer vaccine trials. Fred Hutch will leverage Amazon’s machine learning

Seattle’s life science industry is booming. With top institutions such as Fred Hutchinson Cancer Research Center, the Allen Institute for Brain Science and the Institute